{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:23:22Z","timestamp":1783531402555,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,6,12]],"date-time":"2014-06-12T00:00:00Z","timestamp":1402531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40618-014-0089-2","type":"journal-article","created":{"date-parts":[[2014,6,11]],"date-time":"2014-06-11T09:40:00Z","timestamp":1402479600000},"page":"715-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome"],"prefix":"10.1007","volume":"37","author":[{"given":"Esra Nur","family":"Ademoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suheyla","family":"Gorar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Carl\u0131oglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Havva","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Dilek","family":"Dellal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Berberoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feridun","family":"Karakurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,12]]},"reference":[{"key":"89_CR1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1210\/en.2007-1276","volume":"149","author":"D Kohno","year":"2008","unstructured":"Kohno D, Nakata M, Maejima Y et al (2008) Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 149:1295\u20131301","journal-title":"Endocrinology"},{"key":"89_CR2","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/en.2007-0701","volume":"148","author":"GC Brailoiu","year":"2007","unstructured":"Brailoiu GC, Dun SL, Brailoiu E et al (2007) Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148:5088\u20135094","journal-title":"Endocrinology"},{"key":"89_CR3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature05162","volume":"443","author":"IS Oh","year":"2006","unstructured":"Oh IS, Shimizu H, Satoh T et al (2006) Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443:709\u2013712","journal-title":"Nature"},{"key":"89_CR4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2009.02.104","volume":"381","author":"R Gonzalez","year":"2009","unstructured":"Gonzalez R, Tiwari A, Unniappan S (2009) Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 381:643\u2013664","journal-title":"Biochem Biophys Res Commun"},{"key":"89_CR5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/157339908783502352","volume":"4","author":"T Yada","year":"2008","unstructured":"Yada T, Dezaki K, Sone H et al (2008) Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev 4:18\u201323","journal-title":"Curr Diabetes Rev"},{"key":"89_CR6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(02)01434-6","volume":"440","author":"JJ Meier","year":"2002","unstructured":"Meier JJ, Gallwitz B, Schmidt WE et al (2002) Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 440:269\u2013279","journal-title":"Eur J Pharmacol"},{"key":"89_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1507\/endocrj.K11E-056","volume":"58","author":"M Nakata","year":"2011","unstructured":"Nakata M, Manaka K, Yamamoto S et al (2011) Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca2+ influx through L-type channels in mouse islet \u03b2-cells. Endocr J 58:305\u2013313","journal-title":"Endocr J"},{"key":"89_CR8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1210\/en.2008-0747","volume":"150","author":"A Stengel","year":"2009","unstructured":"Stengel A, Goebel M, Yakubov I et al (2009) Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150:232\u2013238","journal-title":"Endocrinology"},{"key":"89_CR9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","volume":"352","author":"DA Ehrman","year":"2005","unstructured":"Ehrman DA (2005) Polycystic ovary syndrome. N Engl Med 352:1223\u20131236","journal-title":"N Engl Med"},{"key":"89_CR10","doi-asserted-by":"crossref","first-page":"E480","DOI":"10.1210\/jc.2010-1658","volume":"96","author":"E Kandaraki","year":"2011","unstructured":"Kandaraki E, Chatzigeorgiou A, Livanas S et al (2011) Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab 96:E480\u2013E484","journal-title":"J Clin Endocrinol Metab"},{"key":"89_CR11","first-page":"743","volume":"131","author":"S Mukherjee","year":"2010","unstructured":"Mukherjee S, Maitra A (2010) Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res 131:743\u2013760","journal-title":"Indian J Med Res"},{"key":"89_CR12","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","volume":"26","author":"D Dewailly","year":"2011","unstructured":"Dewailly D, Gronier H, Poncelet E et al (2011) Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 26:3123\u20133129","journal-title":"Hum Reprod"},{"key":"89_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0031-1286339","volume":"120","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Li L, Yang M et al (2012) Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 120:91\u201395","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"89_CR14","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s12020-012-9638-7","volume":"42","author":"R Deniz","year":"2012","unstructured":"Deniz R, Gurates B, Aydin S et al (2012) Nesfatin-1 and other hormone alterations in polycystic ovary syndrome. Endocrine 42:694\u2013699","journal-title":"Endocrine"},{"key":"89_CR15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2265.2010.03835.x","volume":"73","author":"T Tsuchiya","year":"2010","unstructured":"Tsuchiya T, Shimizu H, Yamada M et al (2010) Fasting concentrations of nesfatin-1 are negatively correlated with body mass index in non-obese males. Clin Endocrinol (Oxf) 73:484\u2013490","journal-title":"Clin Endocrinol (Oxf)"},{"key":"89_CR16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.regpep.2009.11.003","volume":"159","author":"QC Li","year":"2010","unstructured":"Li QC, Wang HY, Chen X et al (2010) Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept 159:72\u201377","journal-title":"Regul Pept"},{"key":"89_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1677\/JOE-09-0254","volume":"204","author":"KS Foo","year":"2010","unstructured":"Foo KS, Brauner H, Ostenson CG et al (2010) Nucleobindin-2\/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 204:255\u2013263","journal-title":"J Endocrinol"},{"key":"89_CR18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12020-011-9577-8","volume":"41","author":"M Aslan","year":"2012","unstructured":"Aslan M, Celik O, Celik N et al (2012) Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus. Endocrine 41:424\u2013429","journal-title":"Endocrine"},{"key":"89_CR19","doi-asserted-by":"crossref","first-page":"19052","DOI":"10.1074\/jbc.M700460200","volume":"282","author":"H Iguchi","year":"2007","unstructured":"Iguchi H, Urashima Y, Inagaki Y et al (2007) SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation. J Biol Chem 282:19052\u201319061","journal-title":"J Biol Chem"},{"key":"89_CR20","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1210\/en.2009-1358","volume":"151","author":"M Ramanjaneya","year":"2010","unstructured":"Ramanjaneya M, Chen J, Brown JE et al (2010) Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 151:3169\u20133180","journal-title":"Endocrinology"},{"key":"89_CR21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.regpep.2011.09.010","volume":"173","author":"JF Saldanha","year":"2012","unstructured":"Saldanha JF, Carrero JJ, Lobo JC et al (2012) The newly identified anorexigenic adipokine nesfatin-1 in hemodialysis patients: are there associations with food intake, body composition and inflammation? Regul Pept 173:82\u201385","journal-title":"Regul Pept"},{"key":"89_CR22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/en.2008-0598","volume":"150","author":"H Shimizu","year":"2009","unstructured":"Shimizu H, Oh-I S, Hashimoto K et al (2009) Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 150:662\u2013671","journal-title":"Endocrinology"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-014-0089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-014-0089-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T17:05:58Z","timestamp":1716829558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-014-0089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,12]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1007\/s40618-014-0089-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,12]]}}}